Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 27735 | 222 | 29.0 | 30% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
| 139 | 3 | THYROID//THYROID CANCER//GRAVES DISEASE | 64904 |
| 856 | 2 | HYPOTHYROIDISM//SUBCLINICAL HYPOTHYROIDISM//HYPERTHYROIDISM | 11613 |
| 27735 | 1 | ADRENOCEPTOR BRAIN CORTEX//AGING IMPAIRMENT REVERSIBILITY//AGING OF MOUSE | 222 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | ADRENOCEPTOR BRAIN CORTEX | authKW | 137547 | 0% | 100% | 1 |
| 2 | AGING IMPAIRMENT REVERSIBILITY | authKW | 137547 | 0% | 100% | 1 |
| 3 | AGING OF MOUSE | authKW | 137547 | 0% | 100% | 1 |
| 4 | ALFA1 ADRENOCEPTORS | authKW | 137547 | 0% | 100% | 1 |
| 5 | BETA ADRENERGIC RECEPTOR BLOCKING DRUG | authKW | 137547 | 0% | 100% | 1 |
| 6 | BETA ADRENOCEPTORS UP REGULATION | authKW | 137547 | 0% | 100% | 1 |
| 7 | BIOCHEM GERONTOL VIA BIRARELLI 8 | address | 137547 | 0% | 100% | 1 |
| 8 | BIOCHEM GERONTOL VILEG IT SECT | address | 137547 | 0% | 100% | 1 |
| 9 | CAMPHOR VAPOR EXPOSITION | authKW | 137547 | 0% | 100% | 1 |
| 10 | CHAIR THER Y 2 | address | 137547 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Geriatrics & Gerontology | 1869 | 16% | 0% | 35 |
| 2 | Endocrinology & Metabolism | 841 | 24% | 0% | 54 |
| 3 | Pharmacology & Pharmacy | 282 | 23% | 0% | 50 |
| 4 | Medicine, General & Internal | 281 | 18% | 0% | 39 |
| 5 | Medicine, Research & Experimental | 29 | 5% | 0% | 12 |
| 6 | Physiology | 17 | 4% | 0% | 9 |
| 7 | CYTOLOGY & HISTOLOGY | 16 | 0% | 0% | 1 |
| 8 | Primary Health Care | 14 | 1% | 0% | 2 |
| 9 | Toxicology | 9 | 3% | 0% | 6 |
| 10 | Biology | 6 | 2% | 0% | 5 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | BIOCHEM GERONTOL VIA BIRARELLI 8 | 137547 | 0% | 100% | 1 |
| 2 | BIOCHEM GERONTOL VILEG IT SECT | 137547 | 0% | 100% | 1 |
| 3 | CHAIR THER Y 2 | 137547 | 0% | 100% | 1 |
| 4 | NIHHOPKINS BAYVIEW MED | 137547 | 0% | 100% | 1 |
| 5 | NINEWELLS HOSP MED ANAESTHESIA | 137547 | 0% | 100% | 1 |
| 6 | MIE CHUOU MED | 68772 | 0% | 50% | 1 |
| 7 | OSTRA HOSP PATHOL | 68772 | 0% | 50% | 1 |
| 8 | MIL MED HRADEC KRALOVE | 45848 | 0% | 33% | 1 |
| 9 | NINEWELLS HOSP MED SURG | 34385 | 0% | 25% | 1 |
| 10 | OSTRA HOSP MED | 11460 | 0% | 8% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ARCHIVES OF GERONTOLOGY AND GERIATRICS | 4714 | 5% | 0% | 11 |
| 2 | JOURNAL OF MOLECULAR MEDICINE | 4435 | 0% | 3% | 1 |
| 3 | JOURNAL OF THE AMERICAN AGING ASSOCIATION | 2864 | 0% | 2% | 1 |
| 4 | ACTA ENDOCRINOLOGICA | 2840 | 4% | 0% | 9 |
| 5 | THERAPIE | 2645 | 3% | 0% | 7 |
| 6 | CLINICAL ENDOCRINOLOGY | 2212 | 5% | 0% | 11 |
| 7 | HORMONE AND METABOLIC RESEARCH | 1754 | 4% | 0% | 9 |
| 8 | GERONTOLOGY | 1635 | 2% | 0% | 5 |
| 9 | MECHANISMS OF AGEING AND DEVELOPMENT | 1230 | 3% | 0% | 6 |
| 10 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 1148 | 3% | 0% | 7 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | GEFFNER, DL , HERSHMAN, JM , (1992) BETA-ADRENERGIC-BLOCKADE FOR THE TREATMENT OF HYPERTHYROIDISM.AMERICAN JOURNAL OF MEDICINE. VOL. 93. ISSUE 1. P. 61-68 | 33 | 60% | 47 |
| 2 | BOUVIER, N , MILLART, H , (1998) BETA-ADRENOCEPTOR BLOCKING DRUG PHARMACOKINETICS IN HYPERTHYROIDISM. THERAPEUTIC RELEVANCE.THERAPIE. VOL. 53. ISSUE 6. P. 523-531 | 17 | 63% | 0 |
| 3 | KASHIWAI, T , TADA, H , TAMAKI, H , HIDAKA, Y , ITO, E , IWATANI, Y , AMINO, N , (1994) REDUCING EFFECT OF NADOLOL ON SERUM LEVELS OF FREE THYROID-HORMONES IN HYPERTHYROIDISM.ENDOCRINE JOURNAL. VOL. 41. ISSUE 6. P. 717-723 | 14 | 82% | 0 |
| 4 | FEELY, J , PEDEN, N , (1984) USE OF BETA-ADRENOCEPTOR BLOCKING-DRUGS IN HYPERTHYROIDISM.DRUGS. VOL. 27. ISSUE 5. P. 425-446 | 27 | 60% | 38 |
| 5 | VITICCHI, C , BASSO, A , GRINTA, R , PIANTANELLI, L , (1997) THYROID-THYMUS INTERACTION ON BETA-ADRENOCEPTOR REGULATION DURING DEVELOPMENT AND AGEING.GERONTOLOGY. VOL. 43. ISSUE 5. P. 268-276 | 11 | 65% | 3 |
| 6 | FEELY, J , (1983) CLINICAL PHARMACOKINETICS OF BETA-ADRENOCEPTOR BLOCKING-DRUGS IN THYROID-DISEASE.CLINICAL PHARMACOKINETICS. VOL. 8. ISSUE 1. P. 1-16 | 17 | 81% | 14 |
| 7 | MAUNAND, B , VARROUDVIAL, M , (1984) PREPARATION OF THYROTOXIC PATIENTS TO SUB TOTAL THYROIDECTOMY BY BETA BLOCKING-DRUGS ALONE.ANNALES D ENDOCRINOLOGIE. VOL. 45. ISSUE 3. P. 165-172 | 18 | 69% | 2 |
| 8 | OSTERMANN, G , FRENEAUX, E , LEJEUNNE, C , DURLACH, V , GROSS, A , LEUTENEGGER, M , (1988) INFLUENCE OF THYROID-DYSFUNCTION ON PHARMACOKINETICS OF DRUGS.THERAPIE. VOL. 43. ISSUE 4. P. 285-291 | 13 | 59% | 1 |
| 9 | WILKINSON, R , (1983) THERAPEUTIC PROGRESS .10. BETA-BLOCKADE IN THE MANAGEMENT OF THYROTOXICOSIS.JOURNAL OF CLINICAL AND HOSPITAL PHARMACY. VOL. 8. ISSUE 4. P. 323-332 | 14 | 74% | 0 |
| 10 | GEFFNER, DL , SLADEK, J , HERSHMAN, JM , (1990) PHARMACOKINETICS AND CLINICAL EFFECTS OF ATENOLOL IN THERAPY OF HYPERTHYROIDISM.DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH. VOL. 16. ISSUE 4. P. 167-173 | 10 | 59% | 6 |
Classes with closest relation at Level 1 |